26 January 2018

Calls for NAFTA IP chapter to be abolished

More than 100 organisations have expressed concerns over the North American Free Trade Agreement ( NAFTA) renegotiations, suggesting that the IP chapter should be abolished.

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

Americas

Concerns raised over NAFTA biologic data proposal

31 August 2018 A proposal in the North American Free Trade Agreement to set the length of biologic data exclusivity at ten years would harm patients, according to generic associations.

Americas

US Chamber of Commerce criticises Canada’s ‘promise doctrine’

23 March 2017 The US Chamber of Commerce has urged the Canadian government to address its ‘promise utility doctrine’, claiming that it “dramatically undermines legal certainty for medical innovators in Canada”.

More features

Killing the golden goose of US drug innovation (Part II): Drug pricing myths

Former pharma GC brings in-house perspective to McGuireWoods

Sandoz eyes US biosimilar launch as Regeneron settles

Buchalter brings in new partner to head up medtech

Trump’s march-in rights threat: Why pharma is rethinking collaborations

UK gets new IP minister following cabinet reshuffle

Barnes & Thornburg reveals five new IP leaders

Former PTAB judge joins Sterne Kessler

Calls for NAFTA IP chapter to be abolished

More on this story

Editor's picks

Editor's picks

More features